Similarly, Akt2 is associated with proliferation, and phosphorylation at that particular site with activation [20], MITF promotes cell proliferation and invasion through the yes-associated protein 1 (YAP) signaling [21], a molecule associated with negative prognosis in triple-negative breast cancer [22]. Here, AKT2 is linked to triple-negative breast carcinoma.